125 related articles for article (PubMed ID: 37723066)
1. [Evaluation of the efficacy of TIPS in 27 patients with hepatic sinus obstruction syndrome in the near and medium term].
Wang L; Zhang Y; Wang XQ; Yue ZD; Fan ZH; Wu YF; Liu FQ; Dong J; Zhang K; Jiang L; Ding HG; Zhang YN
Zhonghua Gan Zang Bing Za Zhi; 2023 Aug; 31(8):842-846. PubMed ID: 37723066
[No Abstract] [Full Text] [Related]
2. Transjugular intrahepatic portosystemic shunt for hepatic sinusoidal obstruction syndrome associated with consumption of Gynura segetum.
Zhang L; Li Q; Makamure J; Zhao D; Liu Z; Zheng C; Liang B
BMC Gastroenterol; 2021 Jan; 21(1):26. PubMed ID: 33423668
[TBL] [Abstract][Full Text] [Related]
3. Risk factors of poor prognosis in patients with pyrrolidine alkaloid-induced hepatic sinusoidal obstruction syndrome after transjugular intrahepatic portosystemic shunt.
Xiao J; Tu J; Zhang H; Zhang F; Zhang W; Xu H; Yin Q; Yang J; Han H; Wang Y; Zhang B; Peng C; Zou X; Zhang M; Zhuge Y
Hepatol Int; 2021 Jun; 15(3):720-729. PubMed ID: 33507485
[TBL] [Abstract][Full Text] [Related]
4. [Study of PA-HSOS severity grading to predict the prognosis of patients with PA-HSOS treated by transjugular intrahepatic portosystemic shunt].
Chen YR; Zhang W; Zhang M; Zhang F; Xiao JQ; Yin Q; Zhuge YZ
Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):46-53. PubMed ID: 33541023
[No Abstract] [Full Text] [Related]
5. Transjugular intrahepatic portosystemic shunt for pyrrolizidine alkaloid-related hepatic sinusoidal obstruction syndrome.
Zhou CZ; Wang RF; Lv WF; Fu YQ; Cheng DL; Zhu YJ; Hou CL; Ye XJ
World J Gastroenterol; 2020 Jun; 26(24):3472-3483. PubMed ID: 32655270
[TBL] [Abstract][Full Text] [Related]
6. Transjugular intrahepatic portosystemic shunt for pyrrolidine alkaloids-induced hepatic sinusoidal obstruction syndrome: a retrospective cohort study.
Huang T; Zhang X; Yan K; Lou D; He Y; Dai S; Zheng D; Chen P; Wu F; Gu L
Eur J Gastroenterol Hepatol; 2023 Sep; 35(9):1004-1011. PubMed ID: 37395216
[TBL] [Abstract][Full Text] [Related]
7. [Comparison of the curative effect of transjugular intrahepatic portosystemic shunt with expanded polytetrafluoroethylene-covered stent and drug combined with gastroscopy as the secondary prevention of esophageal -gastric variceal bleeding in portal hypertension].
Lin ZP; Chen SL; Wang JY; Liu F; Tan Q; Peng QF; Zhao JB
Zhonghua Gan Zang Bing Za Zhi; 2020 Aug; 28(8):672-678. PubMed ID: 32911906
[No Abstract] [Full Text] [Related]
8. Transjugular Intrahepatic Portosystemic Shunt Benefits for Hepatic Sinusoidal Obstruction Syndrome Associated with Consumption of Gynura Segetum: a Propensity Score-Matched Analysis.
Li S; Li Y; Zhou C; Li H; Chen C; Peng C; Wang T; Liu F; Xiao J; Shi L
Cardiovasc Intervent Radiol; 2023 Jul; 46(7):931-942. PubMed ID: 37225971
[TBL] [Abstract][Full Text] [Related]
9. Timing and efficacy of transjugular intrahepatic portosystemic shunt in patients with pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
Wu F; Yu J; Gan H; Zhang H; Tian D; Zheng D
Sci Rep; 2021 Nov; 11(1):21743. PubMed ID: 34741082
[TBL] [Abstract][Full Text] [Related]
10. Shunting branch of portal vein and stent position predict survival after transjugular intrahepatic portosystemic shunt.
Bai M; He CY; Qi XS; Yin ZX; Wang JH; Guo WG; Niu J; Xia JL; Zhang ZL; Larson AC; Wu KC; Fan DM; Han GH
World J Gastroenterol; 2014 Jan; 20(3):774-85. PubMed ID: 24574750
[TBL] [Abstract][Full Text] [Related]
11. Targeted puncture of left branch of intrahepatic portal vein in transjugular intrahepatic portosystemic shunt to reduce hepatic encephalopathy.
Luo SH; Chu JG; Huang H; Zhao GR; Yao KC
World J Gastroenterol; 2019 Mar; 25(9):1088-1099. PubMed ID: 30862997
[TBL] [Abstract][Full Text] [Related]
12. Mid- to long-term outcomes of initial transjugular intrahepatic portosystemic shunt versus anticoagulation for pyrrolizidine alkaloid-induced hepatic sinusoidal obstruction syndrome.
Huang Q; Zhang Q; Xu H; Zu M; Xiao J; Shen B
Eur J Gastroenterol Hepatol; 2023 Apr; 35(4):445-452. PubMed ID: 36719828
[TBL] [Abstract][Full Text] [Related]
13. [Clinical study of transjugular intrahepatic portosystemic shunt with Viatorr stent in 43 cases].
Zhou H; Yao X; Tang SH; Xie M; Feng ZS; Qin JP
Zhonghua Gan Zang Bing Za Zhi; 2021 Jan; 29(1):54-59. PubMed ID: 33541024
[No Abstract] [Full Text] [Related]
14. Transjugular Intrahepatic Portosystemic Shunt in Liver Transplant Recipients: Outcomes in Six Adult Patients.
Masek J; Fejfar T; Frankova S; Husova L; Krajina A; Renc O; Chovanec V; Raupach J
Vasc Endovascular Surg; 2023 May; 57(4):373-378. PubMed ID: 36593684
[TBL] [Abstract][Full Text] [Related]
15. [Analysis of curative efficacy of transjugular intrahepatic portosystemic shunt using viabahn stent in the treatment of Budd-Chiari syndrome with extensive hepatic vein occlusion].
Zhao C; Zhang QQ; Xu H; Wei N; Cui YF; Liu HT; Wang WL; Xiao JC; Zu MH
Zhonghua Gan Zang Bing Za Zhi; 2021 Oct; 29(10):972-976. PubMed ID: 34814391
[No Abstract] [Full Text] [Related]
16. [Follow-up study of 116 cases of transjugular intrahepatic portosystemic shunt in the treatment of cirrhotic portal hypertension].
Liu MH; Zhou F; Wang XB; Chen LP; Li GZ; Zhao Q
Zhonghua Gan Zang Bing Za Zhi; 2018 Aug; 26(8):596-600. PubMed ID: 30317791
[No Abstract] [Full Text] [Related]
17. [Analysis of the medium-term curative effect of transjugular intrahepatic portosystemic shunt through jugular vein with covered Viatorr stent].
Lin ZP; Zhao JB; Chen SL
Zhonghua Gan Zang Bing Za Zhi; 2019 Jun; 27(6):440-444. PubMed ID: 31357760
[No Abstract] [Full Text] [Related]
18. Severe veno-occlusive disease after allogeneic bone marrow or peripheral stem cell transplantation--role of transjugular intrahepatic portosystemic shunt (TIPS).
Zenz T; Rössle M; Bertz H; Siegerstetter V; Ochs A; Finke J
Liver; 2001 Feb; 21(1):31-6. PubMed ID: 11169070
[TBL] [Abstract][Full Text] [Related]
19. [Clinical efficacy of transjugular intrahepatic portosystemic shunt for gastrointestinal hemorrhage in patients with idiopathic noncirrhotic portal hypertension].
Zhang WW; Ren JZ; Wei T; Wang YP; Xue JF; Chen PF; Zhou XL; Han XW
Zhonghua Nei Ke Za Zhi; 2022 May; 61(5):548-551. PubMed ID: 35488606
[No Abstract] [Full Text] [Related]
20. Transjugular intrahepatic portosystemic shunt for the treatment of hepatic sinusoidal obstruction syndrome caused by pyrrolizidine alkaloids: A multicenter retrospective study.
Wang C; Wang Y; Zhao J; Yang C; Zhu X; Niu H; Sun J; Xiong B
Heliyon; 2024 Jan; 10(1):e23455. PubMed ID: 38163189
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
